Publicacions (46) Publicacions de DAVID ANDALUZ OJEDA

2023

  1. Prevalence of nonalcoholic fatty liver disease in a Spanish town: A population-based study

    Revista Clinica Espanola, Vol. 223, Núm. 7, pp. 396-404

  2. Transcriptomics reveals shared immunosuppressive landscapes in ventilator-associated lower respiratory tract infections (VA-LRTI) patients

    Expert Review of Anti-Infective Therapy, Vol. 21, Núm. 10, pp. 1135-1141

2022

  1. ABO Blood System and COVID-19 Susceptibility: Anti-A and Anti-B Antibodies Are the Key Points

    Frontiers in Medicine, Vol. 9

  2. Dyslipidemia and Inflammation as Hallmarks of Oxidative Stress in COVID-19: A Follow-Up Study

    International Journal of Molecular Sciences, Vol. 23, Núm. 23

2021

  1. Corticosteroid Pulses for Hospitalized Patients with COVID-19: Effects on Mortality

    Mediators of Inflammation, Vol. 2021

  2. Exercise ventilatory inefficiency in post‐covid‐19 syndrome: Insights from a prospective evaluation

    Journal of Clinical Medicine, Vol. 10, Núm. 12

  3. Low-density lipoprotein cholesterol levels are associated with poor clinical outcomes in COVID-19

    Nutrition, Metabolism and Cardiovascular Diseases, Vol. 31, Núm. 9, pp. 2619-2627

  4. MR-proADM as marker of endotheliitis predicts COVID-19 severity

    European Journal of Clinical Investigation, Vol. 51, Núm. 5

  5. Management of infectious complications associated with coronavirus infection in severe patients admitted to ICU

    Medicina Intensiva, Vol. 45, Núm. 8, pp. 485-500

2020

  1. Endothelial dysfunction is an early indicator of sepsis and neutrophil degranulation of septic shock in surgical patients

    BJS open, Vol. 4, Núm. 3, pp. 524-534

  2. MR- proADM to detect specific types of organ failure in infection

    European Journal of Clinical Investigation, Vol. 50, Núm. 6

2019

  1. Composed endotypes to guide antibiotic discontinuation in sepsis

    Critical Care, Vol. 23, Núm. 1

  2. Lymphopenic hospital acquired sepsis (L-HAS): An immunological phenotype conferring higher risk of mortality

    Medicina Intensiva, Vol. 43, Núm. 8, pp. 510-512

  3. Quantification of Immune Dysregulation by Next-generation Polymerase Chain Reaction to Improve Sepsis Diagnosis in Surgical Patients

    Annals of Surgery, Vol. 269, Núm. 3, pp. 545-553

2018

  1. Clinical factors influencing mortality risk in hospital-acquired sepsis

    Journal of Hospital Infection, Vol. 98, Núm. 2, pp. 194-201

2017

  1. Characterizing Systemic Immune Dysfunction Syndrome to Fill in the Gaps of SEPSIS-2 and SEPSIS-3 Definitions

    Chest

  2. Impact of the implementation of a Sepsis Code hospital protocol in antibiotic prescription and clinical outcomes in an intensive care unit

    Medicina Intensiva, Vol. 41, Núm. 1, pp. 12-20

  3. Superior accuracy of mid-regional proadrenomedullin for mortality prediction in sepsis with varying levels of illness severity

    Annals of Intensive Care, Vol. 7, Núm. 1

  4. The protective association of endogenous immunoglobulins against sepsis mortality is restricted to patients with moderate organ failure

    Annals of Intensive Care, Vol. 7, Núm. 1

  5. Ventilator-associated pneumonia by methicillin-susceptible Staphylococcus aureus: do minimum inhibitory concentrations to vancomycin and daptomycin matter?

    European Journal of Clinical Microbiology and Infectious Diseases, Vol. 36, Núm. 9, pp. 1569-1575